Apex Biotechnology Corp (1733) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Apex Biotechnology Corp (1733) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$5.19 Million ≈ $163.42K USD) by net assets (NT$1.81 Billion ≈ $57.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Apex Biotechnology Corp fund operations to measure how many days the company can operate on defensive assets alone.

Apex Biotechnology Corp - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Apex Biotechnology Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Apex Biotechnology Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apex Biotechnology Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sitowise Group Oyj HE:SITOWS	0.162x
Lakeshore Acquisition III Corp. Ordinary Shares NASDAQ:LCCC	-0.002x
SCOPE FLUIDICS SA ZY-10 F:S84	-0.072x
Protech Mitra Perkasa Tbk PT JK:OASA	-0.061x
Beazley plc LSE:BEZ	0.120x
Toma as PR:TOMA	N/A
Hyosung Itx KO:094280	-0.010x
Trinity Precision Technology Co Ltd TWO:4534	0.024x

Annual Cash Flow Conversion Efficiency for Apex Biotechnology Corp (2002–2024)

The table below shows the annual cash flow conversion efficiency of Apex Biotechnology Corp from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Apex Biotechnology Corp market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.82 Billion ≈ $57.47 Million	NT$328.67 Million ≈ $10.35 Million	0.180x	+40.52%
2023-12-31	NT$1.80 Billion ≈ $56.61 Million	NT$230.39 Million ≈ $7.26 Million	0.128x	+775.71%
2022-12-31	NT$1.82 Billion ≈ $57.27 Million	NT$26.62 Million ≈ $838.55K	0.015x	-85.73%
2021-12-31	NT$1.75 Billion ≈ $55.25 Million	NT$179.87 Million ≈ $5.67 Million	0.103x	-39.83%
2020-12-31	NT$1.65 Billion ≈ $51.86 Million	NT$280.60 Million ≈ $8.84 Million	0.170x	-38.20%
2019-12-31	NT$1.68 Billion ≈ $52.83 Million	NT$462.52 Million ≈ $14.57 Million	0.276x	+571.12%
2018-12-31	NT$1.64 Billion ≈ $51.79 Million	NT$67.57 Million ≈ $2.13 Million	0.041x	-3.39%
2017-12-31	NT$1.66 Billion ≈ $52.45 Million	NT$70.83 Million ≈ $2.23 Million	0.043x	-75.27%
2016-12-31	NT$1.73 Billion ≈ $54.58 Million	NT$298.06 Million ≈ $9.39 Million	0.172x	-29.67%
2015-12-31	NT$1.93 Billion ≈ $60.80 Million	NT$472.15 Million ≈ $14.88 Million	0.245x	+70.64%
2014-12-31	NT$1.87 Billion ≈ $58.80 Million	NT$267.60 Million ≈ $8.43 Million	0.143x	-43.20%
2013-12-31	NT$1.92 Billion ≈ $60.51 Million	NT$484.77 Million ≈ $15.27 Million	0.252x	-0.31%
2012-12-31	NT$2.01 Billion ≈ $63.41 Million	NT$509.67 Million ≈ $16.06 Million	0.253x	+62.08%
2011-12-31	NT$1.75 Billion ≈ $55.14 Million	NT$273.45 Million ≈ $8.62 Million	0.156x	-45.31%
2010-12-31	NT$1.63 Billion ≈ $51.35 Million	NT$465.59 Million ≈ $14.67 Million	0.286x	+7.41%
2009-12-31	NT$1.47 Billion ≈ $46.35 Million	NT$391.29 Million ≈ $12.33 Million	0.266x	+12.09%
2008-12-31	NT$1.26 Billion ≈ $39.83 Million	NT$299.96 Million ≈ $9.45 Million	0.237x	-12.21%
2007-12-31	NT$1.35 Billion ≈ $42.50 Million	NT$364.62 Million ≈ $11.49 Million	0.270x	-18.07%
2006-12-31	NT$1.10 Billion ≈ $34.74 Million	NT$363.71 Million ≈ $11.46 Million	0.330x	+39.47%
2005-12-31	NT$896.93 Million ≈ $28.26 Million	NT$212.14 Million ≈ $6.68 Million	0.237x	-6.29%
2004-12-31	NT$865.91 Million ≈ $27.28 Million	NT$218.54 Million ≈ $6.89 Million	0.252x	-29.66%
2003-12-31	NT$842.42 Million ≈ $26.54 Million	NT$302.25 Million ≈ $9.52 Million	0.359x	+221.73%
2002-12-31	NT$712.76 Million ≈ $22.46 Million	NT$79.49 Million ≈ $2.50 Million	0.112x	--

About Apex Biotechnology Corp

TW:1733 Taiwan Biotechnology

Market Cap

$92.11 Million

NT$2.92 Billion TWD

Market Cap Rank

#19603 Global

#1138 in Taiwan

Share Price

NT$29.25

Change (1 day)

+0.00%

52-Week Range

NT$27.05 - NT$37.50

All Time High

NT$42.96